DeLauro Whistles For Investigation Of US FDA Response To Whistleblower Report On Abbott Formula Facility
Appropriations chairwoman Rosa DeLauro wants answers from HHS Office of Inspector General about FDA’s response to whistleblower report of contamination at Abbott Nutrition infant formula facility. Report described pattern of unsatisfactory quality control practices at the plant.
You may also be interested in...
Democrats on Oversight and Investigation Subcommittee support increasing funding for FDA’s regulation of food product manufacturing and marketing, but Republicans advise Commissioner Robert Califf the agency should do more with authority it already has and without adding to its budget.
Democrats introduce bill two days before Agriculture, Rural Development, FDA and Related Agencies subcommittee will question FDA Commissioner Robert Califf about agency’s oversight of formula industry during a hearing on FY2023 budget.
FDA report on inspection states Abbott and agency “found evidence" of Cronobacter species bacteria in powdered infant formula production environment and firm also identified bacteria in finished powdered formula products. Once Abbott gets FDA clearance to restart production at facility, it will need as much as two months before formula made there reaches stores.